Search Results 1601-1610 of 21389 for anti-TNF drugs

1. A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer - Mayo Clinic

   Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for cancer; Concurrent anti-cancer treatment in another investigational ...

2. Neuroblastoma Clinical Trials - Mayo Clinic Research

   Drugs used in chemotherapy, such as isotretinoin, work in different ... anti-cancer drug. The antibody is used to recognize tumor cells so the anti ...

3. Focus Areas - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

   Supercomputer-based approaches to rational drug design; Interaction of drugs and hormones with the genome, biology and toxicology of the cholinergic synapse ...

4. Pneumococcal Vaccine Polyvalent (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Pneumovax 23; Pnu-Imune 23. Canadian ...

5. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

   Any anti-cancer therapy or investigational agents ≤- 4 weeks prior to registration. Failure to recover from prior surgery. Failure to fully recover from ...

6. Technical advances in epilepsy care - Mayo Clinic

   Mayo Clinic uses a range of innovative techniques for the diagnosis and treatment of medication-refractory seizures. Subspecialized expertise can provide ...

7. Tucatinib (Oral Route) Description and Brand Names - Mayo Clinic

   Drugs and Supplements · Tucatinib (Oral Route) ... anti-HER2 breast cancer treatments. Tucatinib is ... Drugs & Supplements; Tucatinib (Oral Route) ...

8. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... [anti-HBc] with or without the presence of ...

9. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Use of intravenous antibacterials, antivirals, anti-fungals, or anti-parasitic agents. Known or suspected active drug and/or alcohol abuse. Human ...

10. Mayo Clinic Proceedings: In the Limelight, December 2021

    Sixth, agents (for example, ACEIs and ARBs) that block the proinflammatory arm of the RAAS may also, unintentionally, interfere with the anti-inflammatory arm ...